SCHEMBL13115367

SCHEMBL13115367

CN(CCNC(=O)Cn1cnc2ccc(Cl)cc21)C1CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 3/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
POLB P06746 1/20 0.42
LMNA P02545 2/20 0.40
ATM Q13315 1/20 0.40
PRPS1 P60891 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
CCNE1 P24864 1/20 0.38
CDK2 P24941 1/20 0.38
CDK5 Q00535 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
RXFP1 Q9HBX9 1/20 0.37
BACE1 P56817 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3597098 0.92 KMT2A (0.42) TRPA1KMT2AMEN1POLBLMNA
SCHEMBL5345349 0.89 TRPA1 (0.43) TRPA1KMT2APOLBLMNAATM
SCHEMBL3605821 0.88 CCNE1 (0.43) KMT2AMEN1POLBATMPRPS1
SCHEMBL5367265 0.87 MTNR1A (0.52) ATMALDH1A1TP53MAPTL3MBTL1
SCHEMBL13115590 0.86 ATM (0.47) ATM
SCHEMBL3602186 0.83 TP53 (0.41) TRPA1KMT2AMEN1POLBCCNE1
SCHEMBL3606205 0.81 TP53 (0.45) KMT2AMEN1ATMSMN1; SMN2ALDH1A1
SCHEMBL13115365 0.81 TRPV1 (0.46) TRPA1KMT2AMEN1ATMPRPS1
SCHEMBL3599700 0.80 ATM (0.42) TRPA1KMT2AMEN1POLBLMNA
SCHEMBL3608391 0.79 GAA (0.42) TRPA1KMT2AMEN1LMNAPRPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275965-A1 CXCR4 modulators CXCL12, CXCR4, CXCR1 TRPA1 2218/4885KMT2A 3838/4885MEN1 4362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.